Navigation Links
InVitria Reports Successful Cell Culture Performance of Zap-CHO, a Defined and Cost Effective CHO Cell Culture Media Supplement
Date:10/28/2009

New Chinese hamster ovary ("CHO") cell culture media supplement delivers enhanced speed, growth and productivity while replacing undefined media components such as hydrolysates or fetal bovine serum ("FBS") in CHO cell culture.

Fort Collins, CO (PRWEB) October 28, 2009 -- InVitria presented the successful performance of its newest CHO cell culture media supplement Zap-CHO during the poster session at BioProcess International '09 in Raleigh, NC. Zap-CHO is a robust cell culture supplement for CHO (Chinese hamster ovary) cells that speeds cell line development, improves growth and antibody productivity.

InVitria designed Zap-CHO to speed cell line development processes and to maximize CHO cell culture performance in biomanufacturing by screening and selecting from several defined and animal-free components that optimize performance. "We tested Zap-CHO in the leading commercial media and confirmed Zap-CHO's performance in chemically-defined and serum-free cell culture media," said Dr. Steve Pettit, InVitria's Director of Cell Culture Development. "In our tests, cell growth increased an average of 190% across all media. Zap-CHO also extended cell viability by delaying apoptosis and increased volumetric productivity an average of 179%."

Zap-CHO is a next generation media supplement that delivers consistent cell culture performance. Zap-CHO provides significant benefits in CHO cell culture, including:

 
  • Faster cell line development and seed train expansion
  • Animal component-free
  • Consistency of a defined media component
  • Biomanufacturing optimization and improved product yield
  • Better and more predictable performance in cell culture research and development

*Through November 20, 2009, InVitria is offering a free Papa John's gift card worth $10.00 with your first online purchase of Zap-CHO. Orders may be placed online at Zap-CHO.

To request a copy of Dr. Pettit's poster, please contact InVitria customer support at 1-800-916-8311 or e-mail info@invitria.com

About InVitria
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture media supplements and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research, medical devices and diagnostics.

For more information about InVitria's products or to order, please contact InVitria at info (at) invitria (dot) com or call 1-800-916-8311.

###

Read the full story at http://www.prweb.com/releases/2009/10/prweb3120484.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. InVitria Launches Zap-CHO to Enhance CHO Cell Culture Performance
2. InVitria's Better Ingredients for Better Media to be Showcased at BPI '09
3. InVitria Presents Zap-CHO Performance Results at PEACe Conference
4. InVitria Successfully Completes Beta Testing and Announces Commercial Launch of Optiferrin for Mammalian Cell Culture
5. InVitria Cell Culture Product Line to Headline PEACe
6. InVitria Sponsors ESACT 2009 in Dublin, Ireland
7. InVitria to Present at BIO 2009 International Convention in Atlanta
8. InVitria Reveals Technology to Optimize Hybridoma Production Performance
9. InVitria Headlines Sponsorship of WilBio's Waterside Conference
10. InVitria Announces Launch of Recombinant Albumin for Diagnostics
11. InVitria's Cell Culture Media Components Showcased at WilBio's 2008 Cell Engineering Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... ... Bellus Medical, a leader in medical aesthetics, recently acquired ... photodynamic cosmetics (PDC). , Allumera® is the first PDC cream specifically formulated to ... minimize the appearance of pores – all with minimal downtime and results that ...
(Date:4/25/2017)... ... April 25, 2017 , ... As President Trump challenges ... for how his administration could impact the employee benefits industry. James Slotnick, AVP, ... most likely to make it through Congress. His discussion will focus on the ...
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies ... to help with process innovation in drug formulation and manufacturing. CoreRx offers ... state-of-the-art analytical equipment in support of their development and manufacturing goals. , ...
(Date:4/25/2017)... CA (PRWEB) , ... April 25, 2017 , ... ... the addition of predictive analytics to its patient care management module. Using this ... even before a patient has been initiated on continuous positive airway pressure (CPAP), ...
(Date:4/24/2017)... Massachusetts (PRWEB) , ... April 24, 2017 , ... ... will help busy nursing professionals advance their careers. Beginning in the fall of 2017, ... Nursing (BSN) degree in as few as 16 months and for as little as ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 Global ... This report on the prostate cancer therapeutics market ... global market. Increasing prevalence of prostate cancer, launch ... in the development of new drugs & therapeutic ... cancer drug due to lesser side effects are ...
(Date:4/19/2017)... 19, 2017  New research provides evidence that an old ... to a study released today that will be presented at ... in Boston , April 22 to 28, ... of Parkinson,s disease, the oral drug levodopa has long been ... But as the disease progresses, the effects of the medication ...
(Date:4/18/2017)... April 18, 2017 Viverae ® , a ... the integration of IBM ® Watson Campaign Automation, ... targeted communications for a personalized experience. Through digital engagement, ... their health in real time. The enhanced experience drives ... to members, wherever they are in their journey to ...
Breaking Medicine Technology: